<DOC>
	<DOCNO>NCT01359917</DOCNO>
	<brief_summary>The hypothesis study : 1 . HIV lipodystrophy associate psychological morbidity relate body image , anxiety depression . 2 . Treatment HIV lipodystrophy use autologous fat transfer , polylactic acid Bio-alcamid , associate improvement psychological morbidity anatomical volume treat area . 3 . The DI3D system valid reproducible method record measure facial 3-D volume .</brief_summary>
	<brief_title>Psychological Morbidity Facial Volume HIV Lipodystrophy : Quantification Treatment Outcome</brief_title>
	<detailed_description />
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>HIV-Associated Lipodystrophy Syndrome</mesh_term>
	<criteria>HIV facial lipoatrophy concurrent antiretrovirals know psychological disorder skin allergy significant medical problem preclude anaesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2006</verification_date>
</DOC>